Oncorus' Series A Round

Oncorus raised a round of funding on April 14, 2016. Investors include MPM Capital.

Oncorus is a pre-clinical stage biotechnology company developing oncolytic HSV products with the potential to recruit all arms of immune system to treat solid tumors.…

Articles about Oncorus' Series A Round: